News
New research reveals that GLP-1 receptor agonists significantly lower mortality risk in older cancer patients with type 2 ...
Ozempic and other GLP-1 weight-loss medications are seeing explosive growth in popularity, but they’re also facing billions ...
GLP-1s aren't FDA-approved to treat rheumatoid arthritis, but many people notice improvement in their inflammation with the ...
Serena Williams opens up about losing over 31 pounds using GLP-1 medication, sharing how it enhanced her healthy lifestyle.
In this second part of a three-part of a video series, Kasey Raetz, Pharm.D., a PBMI Innovator, told MHE about leading the ...
C-store retailers answer this Rovertown ‘hot, or not’ question as well others on GLP-1, Gen Zers and more at Outlook Leadership ...
Dr. Sterling Elliott, Clinical pharmacist at Northwestern Medicine and assistant professor of orthopaedics at Feinberg School ...
Serena Williams sat down with the hosts of Today for a candid interview about her use of GLP-1 medication. The Olympic ...
Tennis legend Serena Williams has revealed that she’s lost 31 pounds over the last eight months using a GLP-1 medication.
Whey, the liquid byproduct of making cheese, was once considered waste. It's now a key ingredient in the protein powders that ...
Serena Williams' suggestion that injectable weight loss drugs could have helped her in tennis is part of an ongoing ...
A study has found that adults with obesity taking GLP-1 receptor agonists may face significantly lower risk of developing certain cancers. The cohort study was led by researchers from the Indiana ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results